Position in LXEO
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$18,147,842
-$3,865,051 QoQ
Shares Held
3,898,570
+1.7% QoQ
Ownership
4.75%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 141 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXEO Over Time
Shares Held
Position Value (USD)
Derivatives in LXEO
reported options exposure · as of Mar 31, 2026CallValue
$61,418
CallShares
10,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. LXEO ranks #70 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in LXEO
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,147,842 | 3,898,570 | Shares | Defined | 2026-09-02 | |
| 2026-03-31 | $22,012,893 | 3,834,999 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $61,418 | 10,700 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $37,478,967 | 3,774,317 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $24,694,444 | 3,719,043 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $14,504,027 | 3,607,967 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $44,416 | 12,800 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $9,450,069 | 2,723,363 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $347 | 100 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $17,919,728 | 2,723,363 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $24,619,201 | 2,723,363 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $41,040,120 | 2,558,611 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $39,246,741 | 2,502,981 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $27,970,567 | 2,084,245 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||